Anti-MAML2 Antibody Clone MAML2/1302

Observed Antibody Staining Data By Tissue Type:

Variations in MAML2 antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in cells in the endometrial stroma in endometrium, cells in the glomeruli in kidney, cells in the tubules in kidney, glandular cells in the adrenal gland, colon, duodenum, prostate, salivary gland and stomach, Leydig cells in the testis, macrophages in lung, Purkinje cells in the cerebellum, respiratory epithelial cells in the bronchus, squamous epithelial cells in the esophagus, oral mucosa and tonsil and urothelial cells in the urinary bladder. More moderate antibody staining intensity was present in cells in the endometrial stroma in endometrium, cells in the glomeruli in kidney, cells in the tubules in kidney, glandular cells in the adrenal gland, colon, duodenum, prostate, salivary gland and stomach, Leydig cells in the testis, macrophages in lung, Purkinje cells in the cerebellum, respiratory epithelial cells in the bronchus, squamous epithelial cells in the esophagus, oral mucosa and tonsil and urothelial cells in the urinary bladder. Low, but measureable presence of MAML2 could be seen inadipocytes in breast, cells in the granular layer in cerebellum, cells in the molecular layer in cerebellum, cells in the red pulp in spleen, cells in the white pulp in spleen, germinal center cells in the tonsil, glandular cells in the endometrium and epididymis, glial cells in the caudate nucleus, hematopoietic cells in the bone marrow, neuronal cells in the hippocampus and neuropil in cerebral cortex. We were unable to detect MAML2 in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.